These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3086889)

  • 1. Slow intravenous administration of low dose aspirin inhibits both vascular and platelet cyclooxygenase activity: an experimental study in the rat.
    Gambino MC; Cerletti C; Marchi S; Garattini S; de Gaetano G
    Proc Soc Exp Biol Med; 1986 Jul; 182(3):287-90. PubMed ID: 3086889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical selectivity of oral versus intravenous aspirin in rats. Inhibition by oral aspirin of cyclooxygenase activity in platelets and presystemic but not systemic vessels.
    Cerletti C; Gambino MC; Garattini S; de Gaetano G
    J Clin Invest; 1986 Jul; 78(1):323-6. PubMed ID: 3088044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selectivity of oral aspirin as an inhibitor of platelet vs. vascular cyclooxygenase activity is reduced by portacaval shunt in rats.
    Gambino MC; Passaghe S; Chen ZM; Bucchi F; Gori G; Latini R; de Gaetano G; Cerletti C
    J Pharmacol Exp Ther; 1988 Apr; 245(1):287-90. PubMed ID: 3129553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology of platelet cyclooxygenase inhibition.
    Patrono C; Ciabattoni G; Patrignani P; Pugliese F; Filabozzi P; Catella F; Davì G; Forni L
    Circulation; 1985 Dec; 72(6):1177-84. PubMed ID: 3933848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of rabbit platelet and aortic cyclooxygenase to inhibition by aspirin.
    McDonald JW; de Kergommeaux BD; Ali M; Hayward CP
    Prostaglandins Leukot Med; 1983 Nov; 12(3):235-44. PubMed ID: 6419233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis.
    Keimowitz RM; Pulvermacher G; Mayo G; Fitzgerald DJ
    Circulation; 1993 Aug; 88(2):556-61. PubMed ID: 8339418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.
    Mehta JL; Mehta P; Lopez L; Ostrowski N; Aguila E
    J Am Coll Cardiol; 1984 Oct; 4(4):806-11. PubMed ID: 6384329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
    Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ
    N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective and nonselective inhibition of thromboxane formation.
    FitzGerald GA; Oates JA
    Clin Pharmacol Ther; 1984 May; 35(5):633-40. PubMed ID: 6370554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic low dose aspirin on platelet and vascular eicosanoid metabolism in nonhuman primates (Macaca fascicularis).
    Jakubowski JA; Bush HL; Vaillancourt R; Deykin D
    Arteriosclerosis; 1987; 7(6):599-604. PubMed ID: 3120680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction.
    de Gaetano G; Cerletti C; Dejana E; Latini R
    Circulation; 1985 Dec; 72(6):1185-93. PubMed ID: 2998640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
    Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
    Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
    Livio M; Benigni A; Zoja C; Begnis R; Morelli C; Rossini M; Garattini S; Remuzzi G
    J Pharmacol Exp Ther; 1989 Jan; 248(1):334-41. PubMed ID: 2492341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of prostacyclin and thromboxane A2 generation by low-dose aspirin at the site of plug formation in man in vivo.
    Kyrle PA; Eichler HG; Jäger U; Lechner K
    Circulation; 1987 May; 75(5):1025-9. PubMed ID: 3552295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
    Clarke RJ; Mayo G; Price P; FitzGerald GA
    N Engl J Med; 1991 Oct; 325(16):1137-41. PubMed ID: 1891022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase.
    Pedersen AK; FitzGerald GA
    N Engl J Med; 1984 Nov; 311(19):1206-11. PubMed ID: 6436696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative inhibitory effect of low-dose aspirin on vascular prostacyclin and platelet thromboxane production in patients with atherosclerosis.
    Weksler BB; Tack-Goldman K; Subramanian VA; Gay WA
    Circulation; 1985 Feb; 71(2):332-40. PubMed ID: 3880671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of the pyrimido-pyrimidine derivatives, dipyridamole and mopidamol, on platelet and vascular cyclooxygenase activity.
    De La Cruz JP; Ortega G; Sánchez de la Cuesta F
    Biochem Pharmacol; 1994 Jan; 47(2):209-15. PubMed ID: 8304965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salicylate-aspirin interaction in the rat. Evidence that salicylate accumulating during aspirin administration may protect vascular prostacyclin from aspirin-induced inhibition.
    Dejana E; Cerletti C; de Castellarnau C; Livio M; Galletti F; Latini R; de Gaetano G
    J Clin Invest; 1981 Oct; 68(4):1108-12. PubMed ID: 6793630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
    Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P
    Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.